Arcellx | 8-K: Arcellx Provides First Quarter 2024 Financial Results
Arcellx | DEFA14A: Others
Arcellx | DEF 14A: Definitive information statements
Arcellx | 8-K: Current report
Arcellx | 8-K: Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Arcellx | 8-K: Current report
Arcellx | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Arcellx | 8-K: Current report
Arcellx | 8-K: Current report
Arcellx | 8-K: Current report
Arcellx | 8-K: Current report
Arcellx | 8-K: Arcellx Provides Third Quarter 2023 Financial Results and Business Highlights
Arcellx | 8-K: Current report
Arcellx | 8-K: Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results
Arcellx | 8-K: Current report
Arcellx | 8-K: Current report
Arcellx | 8-K: Current report
Arcellx | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Arcellx | 8-K: Arcellx Provides First Quarter Financial Results
Arcellx | DEFA14A: Others
No Data